A new CBRE report reveals that as the life science industry continues to boom in the Seattle area, companies are buying out lab space and planning new developments.
A wave of biotech IPOs fueled by pandemic-related interest has been a large part of the excitement, increasing the need for lab spaces as well as the employment numbers for life science careers in the Seattle area.